Sarepta Therapeutics Inc. (SRPT) — Institutional Holders & Catalysts

Fund Holdings

5 fund convergence

AI Signal

Signal Note: Avoro Capital Exit from SRPT

Avoro's exit from Sarepta contrasts with sustained conviction from four other specialist biotech funds, suggesting divergence on near-term catalysts or valuation rather than fundamental thesis rejection. The remaining fund convergence (Casdin, EcoR1, Eventide, Rock Springs) indicates continued belief in SRPT's pipeline—likely tied to upcoming DMD gene therapy or exon-skipping data—but Avoro's departure warrants monitoring for potential clinical/regulatory headwinds.

Unlock full AI analysis — 7-day free trial

2 quarters

Position Trend

Nov 14, 2025

0 funds

Feb 13, 2026

0 funds

Feb 17, 2026

0 funds

Mar 16, 2026

0 funds

-100% total institutional value over 6 quarters

Short Interest

High short interest

Short Shares

22.89M

Change

+3.1%

Days to Cover

10.4

% of Float

25.3%

Settlement

Mar 13, 2026

2 periods

Position Details

Avoro Capital AdvisorsEXITMar 16, 2026

Shares: 0Value: N/A

Casdin CapitalEXITFeb 17, 2026

Shares: 0Value: N/A

+ 18more — see how much conviction went in

See the Full Story

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief:

Sarepta Therapeutics Inc.

Fund Holdings

Position Trend

Short Interest

Catalysts

Position Details

Know which insider moves are real

Insider Signals

Also Held by These Funds

Research Links